HomeNewsBusinessStartupThe startup ecosystem gets its ACT together, sets up fund to help fight COVID-19

The startup ecosystem gets its ACT together, sets up fund to help fight COVID-19

Industry veterans, top VCs and prominent founders have participated in the fund, which will springboard innovators working around fighting the pandemic.

April 01, 2020 / 21:35 IST
Story continues below Advertisement

The startup industry, in yet another major initiative to help fight COVID-19 has come together to create a fund of Rs 100 crore and a pool of experts who can help the sector in this difficult times. This fund will be given out as grants to companies and innovators who can help fight the pandemic.

The initiative, which has been named ACT (Action Covid 19 Team), counts leading entrepreneurs, investors and other industry veterans among its members. They will collaborate with innovators and will partner with startup founders as they deal with the economic carnage caused by the COVID-19 outbreak.

Story continues below Advertisement

Moneycontrol was the first to report on how Indian VCs and startup founders were coming together to form a Rs 100 crore fund. What was evidence of the enthusiasm around this initiative was that more than 40% of the fund got subscribed to within the first few days of the initiative getting launched.

"It seeks platforms that have capital efficient scalable solutions which need initial seed grant to fight COVID-19. Additionally the ACT network will bring its networks, team, money and startup assets to create a force multiplier to help these initiatives make rapid meaningful progress," said the collective in a note released on social media channels.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show